Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Codonopsis root, derived from the plant *Codonopsis pilosula* or related species, is a staple herb in Traditional Chinese Medicine (TCM) known as Dangshen. It is primarily utilized as a Qi tonic to treat deficiencies in the spleen and lungs, addressing clinical symptoms such as fatigue, shortness of breath, poor appetite, and chronic diarrhea. Pharmacologically, the root contains active constituents including polysaccharides, saponins, and alkaloids, which contribute to its immunomodulatory, anti-fatigue, and gastroprotective effects. In modern clinical research, specific formulations such as Lu-Dang-Shen oral liquid have been investigated for their efficacy in improving digestive function in convalescent COVID-19 patients, and the herb is a common component in traditional formulas like Tong Xie Yao Fang for irritable bowel syndrome (IBS).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on codonopsis root.